Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013



Summary



GlobalData's clinical trial report, “Nonmelanomatous Skin Cancer Global Clinical Trials Review, H2, 2013" provides data on the Nonmelanomatous Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonmelanomatous Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonmelanomatous Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nonmelanomatous Skin Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Nations 13
Clinical Trials in G7 Nations by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Nonmelanomatous Skin Cancer 18
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Nonmelanomatous Skin Cancer Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
ZBC Multicare 24
Clinical Trial Overview of ZBC Multicare 24
PharmaQest Pty. Ltd. 25
Clinical Trial Overview of PharmaQest Pty. Ltd. 25
Genextra S.p.a. 26
Clinical Trial Overview of Genextra S.p.a. 26
Healthpoint Biotherapeutics 27
Clinical Trial Overview of Healthpoint Biotherapeutics 27
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
Galderma S.A. 29
Clinical Trial Overview of Galderma S.A. 29
Clinical Trial Overview of Top Institutes / Government 30
National Cancer Institute 30
Clinical Trial Overview of National Cancer Institute 30
Roswell Park Cancer Institute 31
Clinical Trial Overview of Roswell Park Cancer Institute 31
The University of Arizona 32
Clinical Trial Overview of The University of Arizona 32
The University of Sydney 33
Clinical Trial Overview of The University of Sydney 33
The University of Chicago 34
Clinical Trial Overview of The University of Chicago 34
The Cleveland Clinic 35
Clinical Trial Overview of The Cleveland Clinic 35
Baylor College of Medicine 36
Clinical Trial Overview of Baylor College of Medicine 36
North Central Cancer Treatment Group 37
Clinical Trial Overview of North Central Cancer Treatment Group 37
The Medical University of Graz 38
Clinical Trial Overview of The Medical University of Graz 38
Northwestern University 39
Clinical Trial Overview of Northwestern University 39
University of Massachusetts 40
Clinical Trial Overview of University of Massachusetts 40
Case Comprehensive Cancer Center 41
Clinical Trial Overview of Case Comprehensive Cancer Center 41
Oregon Health and Science University 42
Clinical Trial Overview of Oregon Health and Science University 42
Rigshospitalet 43
Clinical Trial Overview of Rigshospitalet 43
University of California, San Diego 44
Clinical Trial Overview of University of California, San Diego 44
Massachusetts General Hospital 45
Clinical Trial Overview of Massachusetts General Hospital 45
National Institute of Arthritis and Musculoskeletal and Skin Diseases 46
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 46
University of Alabama at Birmingham 47
Clinical Trial Overview of University of Alabama at Birmingham 47
University of Wisconsin Madison 48
Clinical Trial Overview of University of Wisconsin Madison 48
University of California, Irvine 49
Clinical Trial Overview of University of California, Irvine 49
Five Key Clinical Profiles 50
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

1.1 List of Tables

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 13
Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 15
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 16
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 17
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 18
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 19
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 22
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZBC Multicare, 2013* 24
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaQest Pty. Ltd., 2013* 25
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2013* 26
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics, 2013* 27
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 28
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2013* 29
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 30
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2013* 31
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2013* 32
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2013* 33
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 34
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 35
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 36
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2013* 37
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 38
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 39
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 40
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013* 41
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 42
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2013* 43
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 44
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 45
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2013* 46
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 47
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 48
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2013* 49

List of Figures

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 13
Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 15
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 16
Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 17
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 22
Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
GlobalData Methodology 70

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Photomedicine: Technologies and Global Markets

Photomedicine: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research study provides a comprehensive analysis of the market of photomedicine. It addresses the drivers and limiters of the market and offers an exhaustive analysis of both drugs and medical ...

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...

Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts

Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts

  • $ 4 995
  • Industry report
  • September 2014
  • by GBI Research

Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts Summary GBI Research, has released its latest pharma report, "Acute Myeloid Leukemia ...

Stem Cell Therapeutics Markets

October 2014 $ 3 995

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.